Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. 2009

Yoshinaga Ito, and Takashi Usui, and Shio Kobayashi, and Mikiko Iguchi-Hashimoto, and Hiromu Ito, and Hiroyuki Yoshitomi, and Takashi Nakamura, and Masakazu Shimizu, and Daisuke Kawabata, and Naoichiro Yukawa, and Motomu Hashimoto, and Noriko Sakaguchi, and Shimon Sakaguchi, and Hajime Yoshifuji, and Takaki Nojima, and Koichiro Ohmura, and Takao Fujii, and Tsuneyo Mimori
Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

OBJECTIVE Although interleukin-17 (IL-17)-producing gamma/delta T cells were reported to play pathogenic roles in collagen-induced arthritis (CIA), their characteristics remain unknown. The aim of this study was to clarify whether gamma/delta T cells or CD4+ T cells are the predominant IL-17-producing cells, and to determine what stimulates gamma/delta T cells to secret IL-17 in mice with CIA. The involvement of IL-17-producing gamma/delta T cells in SKG mice with autoimmune arthritis and patients with rheumatoid arthritis (RA) was also investigated. METHODS IL-17-producing cells in the affected joints of mice with CIA were counted by intracellular cytokine staining during 6 distinct disease phases, and these cells were stimulated with various combinations of cytokines or specific antigens to determine the signaling requirements. Similar studies were performed using SKG mice with arthritis and patients with RA. RESULTS Gamma/delta T cells were the predominant population in IL-17-producing cells in the swollen joints of mice with CIA, and the absolute numbers of these cells increased in parallel with disease activity. IL-17-producing gamma/delta T cells expressed CC chemokine receptor 6, were maintained by IL-23 but not by type II collagen in vitro, and were induced antigen independently in vivo. Furthermore, IL-17 production by gamma/delta T cells was induced by IL-1beta plus IL-23 independently of T cell receptor. In contrast to what was observed in mice with CIA, IL-17-producing gamma/delta T cells were nearly absent in the affected joints of SKG mice and patients with RA, and Th1 cells were predominant in the joints of patients with RA. CONCLUSIONS Gamma/delta T cells were antigen independently stimulated by inflammation at affected joints and produced enhanced amounts of IL-17 to exacerbate arthritis in mice with CIA but not in SKG mice with arthritis or patients with RA.

UI MeSH Term Description Entries
D007596 Joints Also known as articulations, these are points of connection between the ends of certain separate bones, or where the borders of other bones are juxtaposed. Joint
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D006614 Hindlimb Either of two extremities of four-footed non-primate land animals. It usually consists of a FEMUR; TIBIA; and FIBULA; tarsals; METATARSALS; and TOES. (From Storer et al., General Zoology, 6th ed, p73) Hindlimbs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Yoshinaga Ito, and Takashi Usui, and Shio Kobayashi, and Mikiko Iguchi-Hashimoto, and Hiromu Ito, and Hiroyuki Yoshitomi, and Takashi Nakamura, and Masakazu Shimizu, and Daisuke Kawabata, and Naoichiro Yukawa, and Motomu Hashimoto, and Noriko Sakaguchi, and Shimon Sakaguchi, and Hajime Yoshifuji, and Takaki Nojima, and Koichiro Ohmura, and Takao Fujii, and Tsuneyo Mimori
October 2007, Journal of immunology (Baltimore, Md. : 1950),
Yoshinaga Ito, and Takashi Usui, and Shio Kobayashi, and Mikiko Iguchi-Hashimoto, and Hiromu Ito, and Hiroyuki Yoshitomi, and Takashi Nakamura, and Masakazu Shimizu, and Daisuke Kawabata, and Naoichiro Yukawa, and Motomu Hashimoto, and Noriko Sakaguchi, and Shimon Sakaguchi, and Hajime Yoshifuji, and Takaki Nojima, and Koichiro Ohmura, and Takao Fujii, and Tsuneyo Mimori
December 1993, Journal of immunology (Baltimore, Md. : 1950),
Yoshinaga Ito, and Takashi Usui, and Shio Kobayashi, and Mikiko Iguchi-Hashimoto, and Hiromu Ito, and Hiroyuki Yoshitomi, and Takashi Nakamura, and Masakazu Shimizu, and Daisuke Kawabata, and Naoichiro Yukawa, and Motomu Hashimoto, and Noriko Sakaguchi, and Shimon Sakaguchi, and Hajime Yoshifuji, and Takaki Nojima, and Koichiro Ohmura, and Takao Fujii, and Tsuneyo Mimori
July 1999, International immunology,
Yoshinaga Ito, and Takashi Usui, and Shio Kobayashi, and Mikiko Iguchi-Hashimoto, and Hiromu Ito, and Hiroyuki Yoshitomi, and Takashi Nakamura, and Masakazu Shimizu, and Daisuke Kawabata, and Naoichiro Yukawa, and Motomu Hashimoto, and Noriko Sakaguchi, and Shimon Sakaguchi, and Hajime Yoshifuji, and Takaki Nojima, and Koichiro Ohmura, and Takao Fujii, and Tsuneyo Mimori
December 1990, Scandinavian journal of immunology,
Yoshinaga Ito, and Takashi Usui, and Shio Kobayashi, and Mikiko Iguchi-Hashimoto, and Hiromu Ito, and Hiroyuki Yoshitomi, and Takashi Nakamura, and Masakazu Shimizu, and Daisuke Kawabata, and Naoichiro Yukawa, and Motomu Hashimoto, and Noriko Sakaguchi, and Shimon Sakaguchi, and Hajime Yoshifuji, and Takaki Nojima, and Koichiro Ohmura, and Takao Fujii, and Tsuneyo Mimori
September 1996, American journal of respiratory cell and molecular biology,
Yoshinaga Ito, and Takashi Usui, and Shio Kobayashi, and Mikiko Iguchi-Hashimoto, and Hiromu Ito, and Hiroyuki Yoshitomi, and Takashi Nakamura, and Masakazu Shimizu, and Daisuke Kawabata, and Naoichiro Yukawa, and Motomu Hashimoto, and Noriko Sakaguchi, and Shimon Sakaguchi, and Hajime Yoshifuji, and Takaki Nojima, and Koichiro Ohmura, and Takao Fujii, and Tsuneyo Mimori
August 1988, Journal of autoimmunity,
Yoshinaga Ito, and Takashi Usui, and Shio Kobayashi, and Mikiko Iguchi-Hashimoto, and Hiromu Ito, and Hiroyuki Yoshitomi, and Takashi Nakamura, and Masakazu Shimizu, and Daisuke Kawabata, and Naoichiro Yukawa, and Motomu Hashimoto, and Noriko Sakaguchi, and Shimon Sakaguchi, and Hajime Yoshifuji, and Takaki Nojima, and Koichiro Ohmura, and Takao Fujii, and Tsuneyo Mimori
March 2008, Arthritis and rheumatism,
Yoshinaga Ito, and Takashi Usui, and Shio Kobayashi, and Mikiko Iguchi-Hashimoto, and Hiromu Ito, and Hiroyuki Yoshitomi, and Takashi Nakamura, and Masakazu Shimizu, and Daisuke Kawabata, and Naoichiro Yukawa, and Motomu Hashimoto, and Noriko Sakaguchi, and Shimon Sakaguchi, and Hajime Yoshifuji, and Takaki Nojima, and Koichiro Ohmura, and Takao Fujii, and Tsuneyo Mimori
March 1992, Infection and immunity,
Yoshinaga Ito, and Takashi Usui, and Shio Kobayashi, and Mikiko Iguchi-Hashimoto, and Hiromu Ito, and Hiroyuki Yoshitomi, and Takashi Nakamura, and Masakazu Shimizu, and Daisuke Kawabata, and Naoichiro Yukawa, and Motomu Hashimoto, and Noriko Sakaguchi, and Shimon Sakaguchi, and Hajime Yoshifuji, and Takaki Nojima, and Koichiro Ohmura, and Takao Fujii, and Tsuneyo Mimori
January 2002, Experimental gerontology,
Yoshinaga Ito, and Takashi Usui, and Shio Kobayashi, and Mikiko Iguchi-Hashimoto, and Hiromu Ito, and Hiroyuki Yoshitomi, and Takashi Nakamura, and Masakazu Shimizu, and Daisuke Kawabata, and Naoichiro Yukawa, and Motomu Hashimoto, and Noriko Sakaguchi, and Shimon Sakaguchi, and Hajime Yoshifuji, and Takaki Nojima, and Koichiro Ohmura, and Takao Fujii, and Tsuneyo Mimori
January 2002, Clinical and experimental immunology,
Copied contents to your clipboard!